Characteristics of inhibition of pancreatic secretion by glucagon.
D000818:Animals; D002766:Cholecystokinin / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004386:Duodenum / Q000187:drug effects; D005747:Gastric Fistula; D005934:Glucagon / Q000008:administration & dosage / Q000494:pharmacology*; D007275:Injections, Intravenous; D007930:Leucine / Q000037:antagonists & inhibitors; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism; D010185:Pancreatic Fistula; D010189:Pancreatic Juice / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism; D014364:Tryptophan / Q000037:antagonists & inhibitors
D011506:Proteins; D014364:Tryptophan; D005934:Glucagon; D002766:Cholecystokinin; D007930:Leucine